Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9NZ5

MERSmut-CoV M protein dimer in complex with FAb B

Summary for 9NZ5
Entry DOI10.2210/pdb9nz5/pdb
EMDB information49951
DescriptorMembrane protein, FAb B light chain, FAb B heavy chain (3 entities in total)
Functional Keywordsm protein, sars-cov-2, inhibitor bound complex, viral protein, membrane protein-immune system-inhibitor complex, membrane protein/immune system/inhibitor
Biological sourceMiddle East respiratory syndrome-related coronavirus
More
Total number of polymer chains6
Total formula weight155821.41
Authors
Mann, M.K.,Abeywickrema, P. (deposition date: 2025-03-31, release date: 2025-10-29, Last modification date: 2025-12-10)
Primary citationMann, M.K.,Yin, Y.,Marsili, S.,Xie, J.,Doijen, J.,Miller, R.,Piassek, M.,van den Broeck, N.,Kariuki, C.K.,de Gruyter, H.L.M.,Leijs, A.A.,Snijder, E.J.,van Hemert, M.J.,Keustermans, K.,Van Gool, M.,Yu, X.,Loock, M.V.,Koul, A.,Sharma, S.,Van Damme, E.,Abeywickrema, P.
Structural insights into MERS and SARS coronavirus membrane proteins.
Commun Biol, 8:1651-1651, 2025
Cited by
PubMed Abstract: The membrane (M) protein of coronaviruses is essential for maintaining structural integrity during membrane virion budding and viral pathogenesis. Given its high conservation in lineages within the betacoronavirus genus, such as sarbecoviruses, the M protein presents as an attractive therapeutic target; however, developing broad-spectrum antivirals targeting coronaviruses such as MERS-CoV is challenging due to lower sequence conservation and limited structural information available beyond that of the SARS-CoV-2 M protein. In this study, we report 3-3.2 Å resolution structures of MERS-CoV M protein, engineered with a SARS-CoV-2-like antibody interface, representing the first human merbecovirus M protein structure, and SARS-CoV M protein structures, with and without a previously identified SARS-CoV-2 M protein inhibitor, JNJ-9676. We highlight the structural differences between the MERS-CoV, SARS-CoV and SARS-CoV-2 M proteins, and present insights into the conservation of the JNJ-9676 binding pocket as well as key differences that could be targeted to accelerate the design of specific MERS-CoV and broad-spectrum antivirals targeting coronavirus M proteins.
PubMed: 41286109
DOI: 10.1038/s42003-025-09042-3
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.15 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon